The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A review of proposed mechanisms for neurodegenerative disease
Open accessAbstract
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS) affect millions and present significant challenges in healthcare and treatment costs. The debate in the field pivots around two hypotheses: synaptic spread and selective vulnerability. Pioneers like Virginia Lee and John Trojanowski have been instrumental in identifying key proteins (tau, alpha-synuclein, TDP-43) central to these diseases. The synaptic spread hypothesis suggests a cell-to-cell propagation of pathogenic proteins across neuronal synapses, influencing disease progression, with studies highlighting the role of proteins like alpha-synuclein and amyloid-beta in this process. In contrast, the selective vulnerability hypothesis proposes inherent susceptibility of certain neurons to degeneration due to factors like metabolic stress, leading to protein aggregation. Recent advancements in neuroimaging, especially PET/MRI hybrid imaging, offer new insights into these mechanisms. While both hypotheses offer substantial evidence, their relative contributions to neurodegenerative processes remain to be fully elucidated. This uncertainty underscores the necessity for continued research, with a focus on these hypotheses, to develop effective treatments for these devastating diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AD shares mechanistic overlap with other neurodegenerative disorders such as Parkinson’s disease and amyotrophic lateral sclerosis, particularly through two complementary mechanisms: the synaptic spread hypothesis, where pathogenic proteins propagate from neuron to neuron across synapses and the selective vulnerability hypothesis, where certain neuronal populations degenerate earlier due to intrin”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 4×
“These researchers had stained for, and found, alpha-synuclein in the neurites of patients with Parkinson’s and in patients with Dementia with Lewy Bodies.”
BackgroundInfluentialUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089 · cited 1×
“In 1991, Lee and Trojanowski demonstrated that tau, a cytoskeletal protein first isolated by Murray Weingarten and Marc Kirschner in 1975 (Weingarten et al., 1975), was a building block in the neurofibrillary tangles that are often associated with Alzheimer’s disease (Lee et al., 1991).”
BackgroundSpillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 2×
“While (Lee et al., 2001)-2-fluoro-D-glucose (FDG) has been used since 1979 (Phelps et al., 1979), there are now also tracers for amyloid beta (Krishnadas et al., 2021) and tau (Okamura et al., 2005).”
BackgroundMethodPhelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366 · cited 3×
“In their critique of the synaptic spread hypothesis, (Walsh and Selkoe, 2016) also are somewhat critical of the notion that Kordower’s autopsies of patients (Kordower et al., 2008a; Kordower et al., 2008b) from the Freed trial (Freed et al., 2001) provide strong support for that hypothesis.”
BackgroundThe spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098
Research works printed but not linked: 4
- 2023, About the registry-national amyotrophic lateral sclerosis (ALS) registry.
- 2020, Overview of Huntington’s disease.
- Kolata, 2001, Parkinson’s research is set back by failure of fetal cell implants.
- 2021, Parkinson’s disease: Challenges, progress, and promise. National institute of neurological disorders and stroke.
Cited by
Neurodegeneration rewires the tumor microenvironment via the neuro–immune–cancer axis
Bautista, J., Coral-Riofrio, E. C., Urresta, S. S., Palacios-Zavala, D., Echeverría, C. E., Araujo‐Abad, S., & López‐Cortés, A. (2025) · iScience · doi:10.1016/j.isci.2025.113550 · Cited by 22
“31 Genetic and epigenetic factors further influence susceptibility to neurodegeneration.”
TREM2 in neurodegeneration and diseases
Abdulkhaliq, A. A., Alasiri, G., Kim, B., Khan, J., Ajoolabady, A., Yousof, S. M., Ren, J., Tuomilehto, J., Borai, A., Alrfaei, B. M., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03505-7 · Cited by 16
“Globally, neurodegenerative diseases [14, 15] are on the rise, manifesting in various forms, with AD and PD being the most prevalent and clinically signi fi cant subsets [16 – 19].”
Opposite causal effects of type 2 diabetes and metformin on Alzheimer's disease
Liu, D., Cao, H., Baranova, A. V., Xu, C., & Zhang, F. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100129 · Cited by 12
“Additionally, protein aggregation, particularly of islet amyloid polypeptide in T2D, parallels the amyloid-beta and tau protein aggregation seen in AD [ 35 , 36 ].”
Synaptic Function and Dysfunction: New Frontiers in CNS Disorders
Aslan, F. Ş., Akdag, M. B., Doğanyiğit, Z., Okan, A., Shaikh, M. F., & Akyuz, E. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70033 · Cited by 6
“The early emergence of cognitive and behavioral symptoms in various mental disorders indicates that disease onset often begins at the synapse level (Taoufik et al. 2018; Kelser et al. 2024).”
Marine Derived Strategies Against Neurodegeneration
Toulis, V., Marfany, G., & Mirra, S. (2025) · Marine Drugs · doi:10.3390/md23080315 · Cited by 7
“These processes lead to the gradual breakdown of neural networks, synaptic dysfunction, and functional impairment [4].”
Metadata
- Authors
- Kelser, B. M., Teichner, E. M., Subtirelu, R. C., & Hoss, K. N.
- Affiliations
- Case Western Reserve University (US)
- University of Pennsylvania (US)
- Corresponding author
- Kelser, Benjamin M.
- ORCID
- Teichner, Eric M.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2024-10-08
- Volume
- 16
- Pages
- 1370580-1370580
- ISSN
- 1663-4365 (ISSN-L)
- PMC
- PMC11493710
- OpenAlex
- W4403236785
- Cited by
- 20
- References
- 50
- Citations by year
- 2026: 11 · 2025: 9
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Aging Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, tau protein, alpha-synuclein, TDP-43, amyloid-beta, protein aggregation, metabolic stress, PET/MR imaging, disease progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of proposed mechanisms for neurodegenerative disease. https://app.cochat.ai/papers/10.3389/fnagi.2024.1370580
- The paper
- Kelser, B. M., Teichner, E. M., Subtirelu, R. C., & Hoss, K. N. (2024). A review of proposed mechanisms for neurodegenerative disease. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2024.1370580
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.